OPA1 and autosomal dominant optic atrophy: The same center previously established the prevalence of DOA using North of England neurogenetic and ophthalmology clinical databases.13 Seventy-six patients from 22 families were identified with a clinical diagnosis of DOA, and OPA1 gene sequencing was performed on this group.